Ibalizumab: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Ibalizumab. Educational only — not medical advice.
Labeled uses
TROGARZO, in combination with other antiretroviral(s), is indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in heavily treatment-experienced adults with multidrug resistant HIV-1 infection failing their current antiretroviral regimen.
Source: FDA labeling via NIH DailyMed (set c548ad82…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.